Limitations of Nasal Nitric Oxide Measurement for Diagnosis of Primary Ciliary Dyskinesia with Normal Ultrastructure
Primary ciliary dyskinesia (PCD) is a heterogeneous, multisystem disorder characterized by defective ciliary beating. Diagnostic guidelines of the American Thoracic Society (ATS) and European Respiratory Society (ERS) recommend measurement of nasal nitric oxide (nNO) for PCD diagnosis. Several studi...
Gespeichert in:
Veröffentlicht in: | Annals of the American Thoracic Society 2022-08, Vol.19 (8), p.1275-1284 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1284 |
---|---|
container_issue | 8 |
container_start_page | 1275 |
container_title | Annals of the American Thoracic Society |
container_volume | 19 |
creator | Raidt, Johanna Krenz, Henrike Tebbe, Johannes Große-Onnebrink, Jörg Olbrich, Heike Loges, Niki Tomas Biebach, Luisa Schmalstieg, Christian Keßler, Christina Wallmeier, Julia Dworniczak, Bernd Pennekamp, Petra Dugas, Martin Werner, Claudius Omran, Heymut |
description | Primary ciliary dyskinesia (PCD) is a heterogeneous, multisystem disorder characterized by defective ciliary beating. Diagnostic guidelines of the American Thoracic Society (ATS) and European Respiratory Society (ERS) recommend measurement of nasal nitric oxide (nNO) for PCD diagnosis. Several studies demonstrated low nNO-production rates in PCD individuals but underlying causes remain elusive.
To determine nNO-production rates in a well-characterized PCD cohort including subgroup analyses with regard to ultrastructural and ciliary beating phenotypes.
This study included 301 individuals assessed according to ERS guidelines. Diagnostic cutoffs for nNO-production rates for this study cohort and subgroups with normal and abnormal ultrastructure were determined. Diagnostic accuracy was also tested for the widely used 77 nl/min-cutoff in this study cohort. The relationship between nNO-production rates and ciliary beat frequencies (CBFs) was evaluated.
The study cohort comprised 180 individuals with definite PCD diagnosis including 160 individuals with genetic diagnosis, 16 individuals with probable PCD diagnosis and 105 disease controls. The 77 nl/min nNO-cutoff showed a test sensitivity of 0.92 and specificity of 0.86. Test sensitivity was lower (0.85) in the subgroup of 47 PCD individuals with normal ultrastructure compared to 133 PCD individuals with abnormal ultrastructure (0.95). The optimal diagnostic cutoff for the nNO-production rate for the whole study cohort was 69.8 nl/min (sensitivity 0.92, specificity 0.89), however it was 107.8 nl/min (sensitivity 0.89, specificity 0.78) for the subgroup of PCD with normal ultrastructure. PCD individuals with normal ultrastructure compared to abnormal ultrastructure showed higher ciliary motility. Consistently, PCD individuals with higher CBFs showed higher nNO-production rates. In addition, laterality defects occurred less frequently in PCD with normal ultrastructure.
Measurements of nNO below the widely used 77 nL/min cutoff are less sensitive in detecting PCD individuals with normal ultrastructure. Our findings indicate, that higher nNO-production in this subgroup with a higher cutoff for the nNO-production rate (107.8 nl/min) and higher residual ciliary motility are dependent on the underlying molecular PCD defect. Higher nNO-production rates, higher residual CBFs and the lower prevalence of laterality defects hamper diagnosis of PCD with normal ultrastructure. Adjusting the cutoff of nNO-production rate to 10 |
doi_str_mv | 10.1513/AnnalsATS.202106-728OC |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2633848592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2698703842</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-c6950fa36e8c232a404ec32cb84df736c79c661dc894385e15c5c8d4b04d1aca3</originalsourceid><addsrcrecordid>eNpdkUtPwzAQhC0Eggr4C5UlLlxS_Igd-1i1vKTSItGeI9dxwCWJwXYE_HvcFjiwl93DNyPNDgBDjEaYYXo17jrVhPHyaUQQwYhnBRGLyQEYEEpYxjnBh7tbZlxSegLOQ9igNIJhUchjcEJZEjImByDObGujitZ1AboazlVQDZzb6K2Gi09bGfhgVOi9aU0XYe08nFr13Llgd_yjt63yX3BiG7vd06_wajsTrIIfNr7AufNtMlw10asQfa9jsjoDR3UKYM5_9ilY3VwvJ3fZbHF7PxnPMk2pjJnmkqFaUW6ETmlUjnKjKdFrkVd1QbkupOYcV1rInApmMNNMiypfo7zCSit6Ci73vm_evfcmxLK1QZumUZ1xfSgJp1TkgkmS0It_6Mb1fvvmRElRoARuKb6ntHcheFOXb_v8JUbltpryr5pyX025qyYJhz_2_bo11Z_stwj6DcmojTM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2698703842</pqid></control><display><type>article</type><title>Limitations of Nasal Nitric Oxide Measurement for Diagnosis of Primary Ciliary Dyskinesia with Normal Ultrastructure</title><source>American Thoracic Society (ATS) Journals Online</source><source>Alma/SFX Local Collection</source><creator>Raidt, Johanna ; Krenz, Henrike ; Tebbe, Johannes ; Große-Onnebrink, Jörg ; Olbrich, Heike ; Loges, Niki Tomas ; Biebach, Luisa ; Schmalstieg, Christian ; Keßler, Christina ; Wallmeier, Julia ; Dworniczak, Bernd ; Pennekamp, Petra ; Dugas, Martin ; Werner, Claudius ; Omran, Heymut</creator><creatorcontrib>Raidt, Johanna ; Krenz, Henrike ; Tebbe, Johannes ; Große-Onnebrink, Jörg ; Olbrich, Heike ; Loges, Niki Tomas ; Biebach, Luisa ; Schmalstieg, Christian ; Keßler, Christina ; Wallmeier, Julia ; Dworniczak, Bernd ; Pennekamp, Petra ; Dugas, Martin ; Werner, Claudius ; Omran, Heymut</creatorcontrib><description>Primary ciliary dyskinesia (PCD) is a heterogeneous, multisystem disorder characterized by defective ciliary beating. Diagnostic guidelines of the American Thoracic Society (ATS) and European Respiratory Society (ERS) recommend measurement of nasal nitric oxide (nNO) for PCD diagnosis. Several studies demonstrated low nNO-production rates in PCD individuals but underlying causes remain elusive.
To determine nNO-production rates in a well-characterized PCD cohort including subgroup analyses with regard to ultrastructural and ciliary beating phenotypes.
This study included 301 individuals assessed according to ERS guidelines. Diagnostic cutoffs for nNO-production rates for this study cohort and subgroups with normal and abnormal ultrastructure were determined. Diagnostic accuracy was also tested for the widely used 77 nl/min-cutoff in this study cohort. The relationship between nNO-production rates and ciliary beat frequencies (CBFs) was evaluated.
The study cohort comprised 180 individuals with definite PCD diagnosis including 160 individuals with genetic diagnosis, 16 individuals with probable PCD diagnosis and 105 disease controls. The 77 nl/min nNO-cutoff showed a test sensitivity of 0.92 and specificity of 0.86. Test sensitivity was lower (0.85) in the subgroup of 47 PCD individuals with normal ultrastructure compared to 133 PCD individuals with abnormal ultrastructure (0.95). The optimal diagnostic cutoff for the nNO-production rate for the whole study cohort was 69.8 nl/min (sensitivity 0.92, specificity 0.89), however it was 107.8 nl/min (sensitivity 0.89, specificity 0.78) for the subgroup of PCD with normal ultrastructure. PCD individuals with normal ultrastructure compared to abnormal ultrastructure showed higher ciliary motility. Consistently, PCD individuals with higher CBFs showed higher nNO-production rates. In addition, laterality defects occurred less frequently in PCD with normal ultrastructure.
Measurements of nNO below the widely used 77 nL/min cutoff are less sensitive in detecting PCD individuals with normal ultrastructure. Our findings indicate, that higher nNO-production in this subgroup with a higher cutoff for the nNO-production rate (107.8 nl/min) and higher residual ciliary motility are dependent on the underlying molecular PCD defect. Higher nNO-production rates, higher residual CBFs and the lower prevalence of laterality defects hamper diagnosis of PCD with normal ultrastructure. Adjusting the cutoff of nNO-production rate to 107.8 nl/min might promote diagnosing PCD with normal ultrastructure.</description><identifier>ISSN: 2329-6933</identifier><identifier>EISSN: 2325-6621</identifier><identifier>DOI: 10.1513/AnnalsATS.202106-728OC</identifier><identifier>PMID: 35202559</identifier><language>eng</language><publisher>United States: American Thoracic Society</publisher><subject>Dyskinesia ; Genotype & phenotype ; Medical diagnosis ; Medical research ; Nitric oxide</subject><ispartof>Annals of the American Thoracic Society, 2022-08, Vol.19 (8), p.1275-1284</ispartof><rights>Copyright American Thoracic Society Aug 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-c6950fa36e8c232a404ec32cb84df736c79c661dc894385e15c5c8d4b04d1aca3</citedby><cites>FETCH-LOGICAL-c339t-c6950fa36e8c232a404ec32cb84df736c79c661dc894385e15c5c8d4b04d1aca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35202559$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Raidt, Johanna</creatorcontrib><creatorcontrib>Krenz, Henrike</creatorcontrib><creatorcontrib>Tebbe, Johannes</creatorcontrib><creatorcontrib>Große-Onnebrink, Jörg</creatorcontrib><creatorcontrib>Olbrich, Heike</creatorcontrib><creatorcontrib>Loges, Niki Tomas</creatorcontrib><creatorcontrib>Biebach, Luisa</creatorcontrib><creatorcontrib>Schmalstieg, Christian</creatorcontrib><creatorcontrib>Keßler, Christina</creatorcontrib><creatorcontrib>Wallmeier, Julia</creatorcontrib><creatorcontrib>Dworniczak, Bernd</creatorcontrib><creatorcontrib>Pennekamp, Petra</creatorcontrib><creatorcontrib>Dugas, Martin</creatorcontrib><creatorcontrib>Werner, Claudius</creatorcontrib><creatorcontrib>Omran, Heymut</creatorcontrib><title>Limitations of Nasal Nitric Oxide Measurement for Diagnosis of Primary Ciliary Dyskinesia with Normal Ultrastructure</title><title>Annals of the American Thoracic Society</title><addtitle>Ann Am Thorac Soc</addtitle><description>Primary ciliary dyskinesia (PCD) is a heterogeneous, multisystem disorder characterized by defective ciliary beating. Diagnostic guidelines of the American Thoracic Society (ATS) and European Respiratory Society (ERS) recommend measurement of nasal nitric oxide (nNO) for PCD diagnosis. Several studies demonstrated low nNO-production rates in PCD individuals but underlying causes remain elusive.
To determine nNO-production rates in a well-characterized PCD cohort including subgroup analyses with regard to ultrastructural and ciliary beating phenotypes.
This study included 301 individuals assessed according to ERS guidelines. Diagnostic cutoffs for nNO-production rates for this study cohort and subgroups with normal and abnormal ultrastructure were determined. Diagnostic accuracy was also tested for the widely used 77 nl/min-cutoff in this study cohort. The relationship between nNO-production rates and ciliary beat frequencies (CBFs) was evaluated.
The study cohort comprised 180 individuals with definite PCD diagnosis including 160 individuals with genetic diagnosis, 16 individuals with probable PCD diagnosis and 105 disease controls. The 77 nl/min nNO-cutoff showed a test sensitivity of 0.92 and specificity of 0.86. Test sensitivity was lower (0.85) in the subgroup of 47 PCD individuals with normal ultrastructure compared to 133 PCD individuals with abnormal ultrastructure (0.95). The optimal diagnostic cutoff for the nNO-production rate for the whole study cohort was 69.8 nl/min (sensitivity 0.92, specificity 0.89), however it was 107.8 nl/min (sensitivity 0.89, specificity 0.78) for the subgroup of PCD with normal ultrastructure. PCD individuals with normal ultrastructure compared to abnormal ultrastructure showed higher ciliary motility. Consistently, PCD individuals with higher CBFs showed higher nNO-production rates. In addition, laterality defects occurred less frequently in PCD with normal ultrastructure.
Measurements of nNO below the widely used 77 nL/min cutoff are less sensitive in detecting PCD individuals with normal ultrastructure. Our findings indicate, that higher nNO-production in this subgroup with a higher cutoff for the nNO-production rate (107.8 nl/min) and higher residual ciliary motility are dependent on the underlying molecular PCD defect. Higher nNO-production rates, higher residual CBFs and the lower prevalence of laterality defects hamper diagnosis of PCD with normal ultrastructure. Adjusting the cutoff of nNO-production rate to 107.8 nl/min might promote diagnosing PCD with normal ultrastructure.</description><subject>Dyskinesia</subject><subject>Genotype & phenotype</subject><subject>Medical diagnosis</subject><subject>Medical research</subject><subject>Nitric oxide</subject><issn>2329-6933</issn><issn>2325-6621</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpdkUtPwzAQhC0Eggr4C5UlLlxS_Igd-1i1vKTSItGeI9dxwCWJwXYE_HvcFjiwl93DNyPNDgBDjEaYYXo17jrVhPHyaUQQwYhnBRGLyQEYEEpYxjnBh7tbZlxSegLOQ9igNIJhUchjcEJZEjImByDObGujitZ1AboazlVQDZzb6K2Gi09bGfhgVOi9aU0XYe08nFr13Llgd_yjt63yX3BiG7vd06_wajsTrIIfNr7AufNtMlw10asQfa9jsjoDR3UKYM5_9ilY3VwvJ3fZbHF7PxnPMk2pjJnmkqFaUW6ETmlUjnKjKdFrkVd1QbkupOYcV1rInApmMNNMiypfo7zCSit6Ci73vm_evfcmxLK1QZumUZ1xfSgJp1TkgkmS0It_6Mb1fvvmRElRoARuKb6ntHcheFOXb_v8JUbltpryr5pyX025qyYJhz_2_bo11Z_stwj6DcmojTM</recordid><startdate>20220801</startdate><enddate>20220801</enddate><creator>Raidt, Johanna</creator><creator>Krenz, Henrike</creator><creator>Tebbe, Johannes</creator><creator>Große-Onnebrink, Jörg</creator><creator>Olbrich, Heike</creator><creator>Loges, Niki Tomas</creator><creator>Biebach, Luisa</creator><creator>Schmalstieg, Christian</creator><creator>Keßler, Christina</creator><creator>Wallmeier, Julia</creator><creator>Dworniczak, Bernd</creator><creator>Pennekamp, Petra</creator><creator>Dugas, Martin</creator><creator>Werner, Claudius</creator><creator>Omran, Heymut</creator><general>American Thoracic Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20220801</creationdate><title>Limitations of Nasal Nitric Oxide Measurement for Diagnosis of Primary Ciliary Dyskinesia with Normal Ultrastructure</title><author>Raidt, Johanna ; Krenz, Henrike ; Tebbe, Johannes ; Große-Onnebrink, Jörg ; Olbrich, Heike ; Loges, Niki Tomas ; Biebach, Luisa ; Schmalstieg, Christian ; Keßler, Christina ; Wallmeier, Julia ; Dworniczak, Bernd ; Pennekamp, Petra ; Dugas, Martin ; Werner, Claudius ; Omran, Heymut</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-c6950fa36e8c232a404ec32cb84df736c79c661dc894385e15c5c8d4b04d1aca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Dyskinesia</topic><topic>Genotype & phenotype</topic><topic>Medical diagnosis</topic><topic>Medical research</topic><topic>Nitric oxide</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Raidt, Johanna</creatorcontrib><creatorcontrib>Krenz, Henrike</creatorcontrib><creatorcontrib>Tebbe, Johannes</creatorcontrib><creatorcontrib>Große-Onnebrink, Jörg</creatorcontrib><creatorcontrib>Olbrich, Heike</creatorcontrib><creatorcontrib>Loges, Niki Tomas</creatorcontrib><creatorcontrib>Biebach, Luisa</creatorcontrib><creatorcontrib>Schmalstieg, Christian</creatorcontrib><creatorcontrib>Keßler, Christina</creatorcontrib><creatorcontrib>Wallmeier, Julia</creatorcontrib><creatorcontrib>Dworniczak, Bernd</creatorcontrib><creatorcontrib>Pennekamp, Petra</creatorcontrib><creatorcontrib>Dugas, Martin</creatorcontrib><creatorcontrib>Werner, Claudius</creatorcontrib><creatorcontrib>Omran, Heymut</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of the American Thoracic Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raidt, Johanna</au><au>Krenz, Henrike</au><au>Tebbe, Johannes</au><au>Große-Onnebrink, Jörg</au><au>Olbrich, Heike</au><au>Loges, Niki Tomas</au><au>Biebach, Luisa</au><au>Schmalstieg, Christian</au><au>Keßler, Christina</au><au>Wallmeier, Julia</au><au>Dworniczak, Bernd</au><au>Pennekamp, Petra</au><au>Dugas, Martin</au><au>Werner, Claudius</au><au>Omran, Heymut</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Limitations of Nasal Nitric Oxide Measurement for Diagnosis of Primary Ciliary Dyskinesia with Normal Ultrastructure</atitle><jtitle>Annals of the American Thoracic Society</jtitle><addtitle>Ann Am Thorac Soc</addtitle><date>2022-08-01</date><risdate>2022</risdate><volume>19</volume><issue>8</issue><spage>1275</spage><epage>1284</epage><pages>1275-1284</pages><issn>2329-6933</issn><eissn>2325-6621</eissn><abstract>Primary ciliary dyskinesia (PCD) is a heterogeneous, multisystem disorder characterized by defective ciliary beating. Diagnostic guidelines of the American Thoracic Society (ATS) and European Respiratory Society (ERS) recommend measurement of nasal nitric oxide (nNO) for PCD diagnosis. Several studies demonstrated low nNO-production rates in PCD individuals but underlying causes remain elusive.
To determine nNO-production rates in a well-characterized PCD cohort including subgroup analyses with regard to ultrastructural and ciliary beating phenotypes.
This study included 301 individuals assessed according to ERS guidelines. Diagnostic cutoffs for nNO-production rates for this study cohort and subgroups with normal and abnormal ultrastructure were determined. Diagnostic accuracy was also tested for the widely used 77 nl/min-cutoff in this study cohort. The relationship between nNO-production rates and ciliary beat frequencies (CBFs) was evaluated.
The study cohort comprised 180 individuals with definite PCD diagnosis including 160 individuals with genetic diagnosis, 16 individuals with probable PCD diagnosis and 105 disease controls. The 77 nl/min nNO-cutoff showed a test sensitivity of 0.92 and specificity of 0.86. Test sensitivity was lower (0.85) in the subgroup of 47 PCD individuals with normal ultrastructure compared to 133 PCD individuals with abnormal ultrastructure (0.95). The optimal diagnostic cutoff for the nNO-production rate for the whole study cohort was 69.8 nl/min (sensitivity 0.92, specificity 0.89), however it was 107.8 nl/min (sensitivity 0.89, specificity 0.78) for the subgroup of PCD with normal ultrastructure. PCD individuals with normal ultrastructure compared to abnormal ultrastructure showed higher ciliary motility. Consistently, PCD individuals with higher CBFs showed higher nNO-production rates. In addition, laterality defects occurred less frequently in PCD with normal ultrastructure.
Measurements of nNO below the widely used 77 nL/min cutoff are less sensitive in detecting PCD individuals with normal ultrastructure. Our findings indicate, that higher nNO-production in this subgroup with a higher cutoff for the nNO-production rate (107.8 nl/min) and higher residual ciliary motility are dependent on the underlying molecular PCD defect. Higher nNO-production rates, higher residual CBFs and the lower prevalence of laterality defects hamper diagnosis of PCD with normal ultrastructure. Adjusting the cutoff of nNO-production rate to 107.8 nl/min might promote diagnosing PCD with normal ultrastructure.</abstract><cop>United States</cop><pub>American Thoracic Society</pub><pmid>35202559</pmid><doi>10.1513/AnnalsATS.202106-728OC</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2329-6933 |
ispartof | Annals of the American Thoracic Society, 2022-08, Vol.19 (8), p.1275-1284 |
issn | 2329-6933 2325-6621 |
language | eng |
recordid | cdi_proquest_miscellaneous_2633848592 |
source | American Thoracic Society (ATS) Journals Online; Alma/SFX Local Collection |
subjects | Dyskinesia Genotype & phenotype Medical diagnosis Medical research Nitric oxide |
title | Limitations of Nasal Nitric Oxide Measurement for Diagnosis of Primary Ciliary Dyskinesia with Normal Ultrastructure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T04%3A34%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Limitations%20of%20Nasal%20Nitric%20Oxide%20Measurement%20for%20Diagnosis%20of%20Primary%20Ciliary%20Dyskinesia%20with%20Normal%20Ultrastructure&rft.jtitle=Annals%20of%20the%20American%20Thoracic%20Society&rft.au=Raidt,%20Johanna&rft.date=2022-08-01&rft.volume=19&rft.issue=8&rft.spage=1275&rft.epage=1284&rft.pages=1275-1284&rft.issn=2329-6933&rft.eissn=2325-6621&rft_id=info:doi/10.1513/AnnalsATS.202106-728OC&rft_dat=%3Cproquest_cross%3E2698703842%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2698703842&rft_id=info:pmid/35202559&rfr_iscdi=true |